SEARCH

SEARCH BY CITATION

References

  • ARENDT, J. (1995). Melatonin and the mammalian pineal gland. London: Chapman and Hall.
  • BERESFORD, I.J.M., BROWNING, C., STARKEY, S.J., BROWN, J., FOORD, S.M., COUGHLAN, J., NORTH, P.C., DUBOCOVICH, M.L. & HAGAN, R.M. (1998a). GR196429: A non-indolic agonist at high-affinity melatonn receptors. J. Pharmacol. Exp. Therap., 285, 12391245.
  • BERESFORD, I.J.M, HARVEY, F.J., HALL, D.A. & GILES, H. (1998b). Pharmacological characterisation of melatonin mt1 receptor mediated stimulation of [35S]-GTPγS binding. Biochem. Pharmacol., 56, 11671174.
  • BLACK, J.W., LEFF, P. & SHANKLEY, N.P. (1985). Further analysis of anomalous pKB values for histamine H2 receptor antagonists on the mouse isolated stomach assay. Br. J. Pharmacol., 86, 581587.
  • BROWNING, C., BERESFORD, I.J.M. & GILES, H. (1998). Differential pharmacological characterisation of human recombinant melatonin mt1 and MT2 receptors. Br. J. Pharmacol., 124, 34P.
  • BROWNING, C., BROWN, J.D., BERESFORD, I.J.M. & GILES, H. (1997). Pharmacological characterisation of [3H]-melatonin binding to human melatonin Mel1A and Mel1B receptors. Br. J. Pharmacol., 120, 361P.
  • CHENG, Y. & PRUSOFF, W.H. (1973). Relationship between the inhibition constant (ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction. Biochem. Pharmacol., 22, 30993108.
  • COHEN, F.R., LAZARENO, S. & BIRDSALL, N.J.M. (1996). The effects of saponin on the binding and functional properties of the human adenosine A1 receptor. Br. J. Pharmacol., 117, 15211529.
  • DUBOCOVICH, M.L. (1988). Luzindole (N-0744): A novel melatonin receptor antagonist. J. Pharmacol. Exp. Therap., 246, 902910.
  • DUBOCOVICH, M.L. (1995). Melatonin receptors: Are there multiple subtypes Trends Pharmacol. Sci., 16, 5056.
  • DUBOCOVICH, M.L. & MASANA, M.I. (1998). The efficacy of melatonin receptor analogues is dependent on the level of human melatonin receptor subtype expression. In: Biological Clocks, Mechanisms and Applications. ed. Touitou, Y. pp. 289293. Amsterdam: Elsevier Science B.V.
  • DUBOCOVICH, M.L., CARDINALI, D.P., GUARDIOLA-LEMAITRE, B., HAGAN, R.M., KRAUSE, D.N., SUGDEN, D., VANHOUTTE, P.M. & YOCCA, F.D. (1998a). Melatonin receptors. In: The IUPHAR Compendium of Receptor Characterisation and Classification. pp. 187193. London: IUPHAR Media.
  • DUBOCOVICH, M.L., MASANA, M.I. & IACOB, S. (1997). Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor. Naunyn Schmeid. Arch. Pharmacol., 355, 365375.
  • DUBOCOVICH, M.L., YUN, K., ALGHOUL, W.M., BENLOUCIF, S., & MASANA, M.I. (1998b). Selective MT2 receptor antagonists block melatonin mediated phase advances of circadian rhythms. FASEB J., 12, 12111220.
  • EBISAWA, T., KARNE, S., LERNER, M.R. & REPPERT, S.M. (1994). Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores. Proc. Natl. Acad. Sci. (U.S.A.), 91, 61336137.
  • FURCHGOTT, R.F. (1966). The use of β-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes. Adv. Drug Res., 3, 2155.
  • KENAKIN, T.P. & BEEK, D. (1980). Is prenalterol (H133/80) really a selective beta 1 adrenoceptor agonist? Tissue selectivity resulting from differences in stimulus-response relationships. J. Pharmacol. Exp. Therap., 213, 406413.
  • KENNAWAY, D.J., HUGEL, H.M. & ROWE, S.A. (1994). Characterisation of the chicken brain melatonin-binding protein using iodinated and tritiated ligands. J. Pineal Res., 17, 137148.
  • LEFF, P. (1987). Can operational models of agonism provide a framework for classifying hormone receptors? In: Perspectives on Receptor Classification. ed. Black, J.W. Jenkinson, D.H. & Gerskowitch, V.P. pp. 157168. New York: Alan R. Liss Inc.
  • LEW, M.J. & ANGUS, J.A. (1995). Analysis of competitive agonist-antagonist interactions by non-linear regression. Trends Pharmacol. Sci., 16, 328337.
  • MORGAN, P.J., BARRETT, P., HAZLERIGG, D., MILLIGAN, G., LAWSON, W., MACLEAN, A. & DAVIDSON, G. (1995). Melatonin receptors couple through a cholera toxin-sensitive mechanism to inhibit cyclic AMP in the ovine pituitary. J. Neuroendocrinnol., 7, 361369.
  • MORGAN, P.J., BARRETT, P., HOWELL, H.E. & HELLIWELL, R. (1994). Melatonin receptors: localisation, molecular pharmacology and physiological significance. Neurochem. Int., 24, 101146.
  • MORGAN, P.J., DAVIDSON, G., LAWSON, W. & BARRETT, P. (1990). Both pertussis toxin-sensitive and insensitive G-proteins link melatonin receptors to inhibition of adenylate cyclase in the ovine pars tuberalis. J. Neuroendocrinol., 2, 773776.
  • NONNO, R., PANNACCI, M., LUCINI, V., ANGELONI, D., FRASCHINI, F. & STANKOV, B.M. (1999). Ligand efficacy and potency at recombinant human MT2 melatonin receptors:evidence for agonist activity of some mt1-antagonists. Br. J. Pharmacol., 127, 12881294.
  • REPPERT, S.M., GODSON, C., MAHLE, C.D., WEAVER, D.R., SLAUGENHAUPT, S.A. & GUSELLA, J.F. (1995). Molecular characterisation of a second melatonin receptor expressed in human retina and brain: The Mel1b melatonin receptor. Proc. Natl. Acad. Sci. (U.S.A.), 92, 87348738.
  • REPPERT, S.M., WEAVER, D.R. & EBISAWA, T. (1994). Cloning and characterisation of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron, 13, 11771185.
  • WEAVER, D.R. & REPPERT, S.M. (1996). The Mel1a melatonin receptor gene is expressed in human suprachiasmatic nuclei. Neuroreport, 8, 109112.
  • WITT-ENDERBY, P.A. & DUBOCOVICH, M.T. (1996). Characterisation and regulation of the human ML1A melatonin receptor stably expressed in Chinese hamster ovary cells. Mol. Pharmacol., 50, 166174.
  • YOUS, Y., ANDRIEUX, J., HOWELL, M.E., MORGAN, P.J., RENARD, P., PFEIFFER, B., LESIEUR, D. & GUARDIOLA-LEMAITRE, B. (1992). Novel naphthalenic ligands with high affinity for the melatonin receptor. J. Med. Chem., 35, 14841486.
  • YUNG, L.Y., TSIM, S. & WONG, Y.H. (1995). Stimulation of cAMP accumulation by the cloned Xenopus melatonin receptor through Gi and Gz proteins. FEBS Letts., 372, 99102.